Pulmonx (LUNG) EBITDA Margin Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.00 |
| Jun 30, 2025 | 1,192.00 |
| Mar 31, 2025 | 1,280.00 |
| Dec 31, 2024 | 1,122.00 |
| Sep 30, 2024 | 1,778.00 |
| Jun 30, 2024 | 1,970.00 |
| Mar 31, 2024 | 3,092.00 |
| Dec 31, 2023 | 2,301.00 |
| Sep 30, 2023 | 2,026.00 |
| Jun 30, 2023 | 1,216.00 |
| Mar 31, 2023 | 4,182.00 |
| Dec 31, 2022 | 221.00 |
| Sep 30, 2022 | -2,838.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | -1,093.00 |
| Dec 31, 2021 | 55.00 |
| Sep 30, 2021 | -4,022.00 |
| Jun 30, 2021 | 21,958.00 |
| Mar 31, 2021 | -5,843.00 |
| Dec 31, 2020 | -4,817.00 |
| Sep 30, 2020 | 1,070.00 |